Claims Analysis
Total Claims: 36
Claim 1
Independent Claim
374 words
A compound of formula (I): ##STR17## wherein: A is O, NH, or N--(C1-C4 alkyl); B and D are independently: (i) Ar 2 , (C5-C7)-cycloalkyl substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkenyl substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, or Ar 2 -substituted (C1-C6)-straight or branched alkyl or Ar 2 -substituted (C2-C6)-straight or branched alkenyl, wherein in each case, any one of the CH 2 groups in said alkyl or alkenyl chains is optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 ; or (ii) ##STR18## wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl; wherein T is Ar 2 or substituted 5-7 membered cycloalkyl with substituents at positions 3 and 4 which are independently selected from the group consisting of hydrogen, oxo, hydroxyl, O--(C1-C4-alkyl) and O--(C2-C4-alkenyl); wherein Ar 2 is selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, and other monocyclic and bicyclic heterocyclic ring systems with individual ring sizes of 5 or 6 which may contain in either or both rings a total of 1 to 4 heteroatoms independently selected from oxygen, nitrogen and sulfur; wherein any occurrence of Ar 2 optionally contains one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O-((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl and phenyl; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen then L is not hydrogen; wherein U is hydrogen, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl, (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, ((C1-C4)-alkyl or (C2-C4)-alkenyl)-Ar 2 or Ar 2 (Ar 2 as defined above); J and K are taken together with the N and C atom to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; m is 0-3; and the stereochemistry at carbon positions 1 and 2 are independently (R) or (S).
Claim 2
Dependent Claim
374 words
A compound of formula (I): ##STR17## wherein: A is O, NH, or N--(C1-C4 alkyl); B and D are independently: (i) Ar 2 , (C5-C7)-cycloalkyl substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkenyl substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, or Ar 2 -substituted (C1-C6)-straight or branched alkyl or Ar 2 -substituted (C2-C6)-straight or branched alkenyl, wherein in each case, any one of the CH 2 groups in said alkyl or alkenyl chains is optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 ; or (ii) ##STR18## wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl; wherein T is Ar 2 or substituted 5-7 membered cycloalkyl with substituents at positions 3 and 4 which are independently selected from the group consisting of hydrogen, oxo, hydroxyl, O--(C1-C4-alkyl) and O--(C2-C4-alkenyl); wherein Ar 2 is selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, and other monocyclic and bicyclic heterocyclic ring systems with individual ring sizes of 5 or 6 which may contain in either or both rings a total of 1 to 4 heteroatoms independently selected from oxygen, nitrogen and sulfur; wherein any occurrence of Ar 2 optionally contains one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O-((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl and phenyl; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen then L is not hydrogen; wherein U is hydrogen, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl, (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, ((C1-C4)-alkyl or (C2-C4)-alkenyl)-Ar 2 or Ar 2 (Ar 2 as defined above); J and K are taken together with the N and C atom to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; m is 0-3; and the stereochemistry at carbon positions 1 and 2 are independently (R) or (S).
Claim 3
Dependent Claim
574 words
A compound of formula (I): ##STR19## wherein: A is CH 2 , oxygen, NH or N--(C1-C4 alkyl); B and D are independently (i) Ar 1 , (C1-C10)-straight or branched alkyl, (C2-C10)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, or Ar 1 -substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl wherein, in each case, any one of the CH 2 groups of said alkyl, alkenyl or alkynyl chains is optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 ; or (ii) ##STR20## wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl; wherein T is Ar 1 or substituted 5-7 membered cycloalkyl with substituents at positions 3 and 4 which are independently selected from the group consisting of oxo, hydrogen, hydroxyl, O--(C1-C4)-alkyl or O--(C2-C4)-alkenyl; provided that at least one of B or D is independently selected from the group consisting of (C2-C10)-straight or branched alkynyl, (C5-C7)-cycloalkyl-substituted (C2-C6)-straight or branched alkynyl, (C5-C7)-cycloalkenyl-substituted (C2-C6)-straight or branched alkynyl, and Ar 1 -substituted (C2-C6)-straight or branched alkynyl; wherein Ar 1 is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, 2-pyrazolinyl, pyrazolidinyl, isoxazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazolyl, 1,3,4-thiadiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl, 1H-indazolyl, benzimidazolyl, benzthiazolyl, purinyl, 4H-quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl; wherein any occurrence of Ar 1 optionally contains one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl, N-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl) carboxamides, N,N-di-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen, then L is not hydrogen; wherein U is hydrogen, O--((C1-C4)-straight or branched alkyl) or O--((C2-C4)straight or branched alkenyl), (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl or (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, ((C1-C4)-alkyl or (C2-C4)-alkenyl)--Y or Y; wherein Y is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group as defined above; wherein Y optionally contains one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C1-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O--benzyl, O-phenyl, 1,2-methylenedioxy, amino, and carboxyl; J and K are taken together with the N and C atom to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; and m is 0-3.
Claim 4
Dependent Claim
574 words
A compound of formula (I): ##STR19## wherein: A is CH 2 , oxygen, NH or N--(C1-C4 alkyl); B and D are independently (i) Ar 1 , (C1-C10)-straight or branched alkyl, (C2-C10)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, or Ar 1 -substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl wherein, in each case, any one of the CH 2 groups of said alkyl, alkenyl or alkynyl chains is optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 ; or (ii) ##STR20## wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl; wherein T is Ar 1 or substituted 5-7 membered cycloalkyl with substituents at positions 3 and 4 which are independently selected from the group consisting of oxo, hydrogen, hydroxyl, O--(C1-C4)-alkyl or O--(C2-C4)-alkenyl; provided that at least one of B or D is independently selected from the group consisting of (C2-C10)-straight or branched alkynyl, (C5-C7)-cycloalkyl-substituted (C2-C6)-straight or branched alkynyl, (C5-C7)-cycloalkenyl-substituted (C2-C6)-straight or branched alkynyl, and Ar 1 -substituted (C2-C6)-straight or branched alkynyl; wherein Ar 1 is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, 2-pyrazolinyl, pyrazolidinyl, isoxazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazolyl, 1,3,4-thiadiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl, 1H-indazolyl, benzimidazolyl, benzthiazolyl, purinyl, 4H-quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl; wherein any occurrence of Ar 1 optionally contains one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl, N-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl) carboxamides, N,N-di-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen, then L is not hydrogen; wherein U is hydrogen, O--((C1-C4)-straight or branched alkyl) or O--((C2-C4)straight or branched alkenyl), (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl or (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, ((C1-C4)-alkyl or (C2-C4)-alkenyl)--Y or Y; wherein Y is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group as defined above; wherein Y optionally contains one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C1-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O--benzyl, O-phenyl, 1,2-methylenedioxy, amino, and carboxyl; J and K are taken together with the N and C atom to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; and m is 0-3.
Claim 5
Dependent Claim
83 words
The compound according to claim 2, wherein said Ar 1 group contains one to three substituents selected from the group consisting of N-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl) carboxamides, N,N-di-((C1-C5)-straight or branched alkyl or alkenyl)carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl, and q is 0-2.
Claim 6
Dependent Claim
31 words
The compound according to any one of claims 1-3, wherein in formula (I), M is O and J and K are taken together to form a pyrrolidine or a piperidine ring.
Claim 7
Dependent Claim
76 words
The compound according to claim 4, wherein in formula (I), B is selected from the group consisting of 3-(2-pyridyl)propyl, 3-phenylpropyl, 2-phenoxypropyl, phenyl, 2(3-pyridyl)ethyl, E-2-[trans-(4-hydroxycyclohexyl)]-1-methyl-ethenyl, 3-(3-pyridyl)propyl, benzyl, 2-phenylethyl, 2-(4-methoxyphenyl)ethyl, 3-(N-benzimidazolyl)propyl, 3-(4-methoxyphenyl)propyl, 3-[N-(7-azaindolyl)]propyl, 3-(N-purinyl)propyl, 3-(3-pyridyl)propyl-N-oxide, 3-(4-hydroxymethylphenyl) propyl, 3-(2-thienyl)propyl, 3-(4-carboxyphenyl)propyl, 4-phenylbutyl, 2-hydroxymethyl-phenyl, 2-allyloxyphenyl, 3-(3-hydroxymethylphenyl, 2-hydroxyphenyl, 3-pyridyl and 5-phenylpentyl; D is selected from the group consisting of 3-phenylpropyl, 2-phenoxyphenyl, 3-(3-indolyl)propyl, 2-phenylethyl, 4-phenylbutyl, and 3-(4-methoxyphenyl)propyl; and L is selected from the group consisting of 3,4,5-trimethoxyphenyl, phenyl, tert-butyl, 3-benzyloxy-phenyl, 3-allyloxyphenyl and 3-isopropoxyphenyl.
Claim 8
Dependent Claim
275 words
A compound of formula (II): ##STR21## wherein n, m, B, D and U are defined as follows: ______________________________________
n m B D U
______________________________________
1 0 3-(Pyridin-2-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
yl)propyl
2 0 3-Phenyl- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
propyl
2 0 2-Phenoxy- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl
2 0 Phenyl 2-Phenoxy-
3,4,5-Trimethoxyphenyl
phenyl
2 0 Phenyl 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
2 0 2-(Pyridin-3-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
yl)ethyl
2 0 E-3-[trans-(4-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
Hydroxy-
cyclohexyl)]-
2-methyl-eth-
2-enyl
2 0 3-(Pyridin-3-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
yl)propyl
2 0 Benzyl 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
2 0 Benzyl 3-(Indol-3-yl)
3,4,5-Trimethoxyphenyl
propyl
2 0 2-Phenylethyl
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
2 0 2-(4-Methoxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl)ethyl
2 0 2-(4-Methoxy-
3-Phenylpropyl
Phenyl
phenyl)ethyl
2 0 3-(N- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
Benzimida-
zolyl)propyl
2 1 Benzyl 2-Phenylethyl
3,4,5-Trimethoxyphenyl
2 0 3-(4-Methoxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl)
propyl
2 0 3-(Pyridin-3-
3-Phenylpropyl
Phenyl
yl)-propyl
2 0 3-(Pyridin-2-
3-Phenylpropyl
Phenyl
yl)-propyl
2 0 3-(Pyridin-2-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
yl)-propyl
2 0 3-(Pyridin-
3-Phenylpropyl
tert-Butyl
2yl)-propyl
2 0 3-(Pyridin-3-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
yl)-propyl
N-oxide
2 0 3-IN-(7- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
Azaindolyl)-
propyl
2 0 3-(Pyridin-
3-(4-Methoxy-
3,4,5-Trimethoxyphenyl
3-yl)-propyl
phenyl)propyl
2 0 3-(N-Purinyl)
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
propyl
2 0 3-(4-Hydroxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
methyl-
phenyl)
propyl
2 0 3-(Pyridin-3-
3-Phenylpropyl
3-Benzyloxyphenyl
yl)-propyl
2 0 3-(Pyridin-3-
3-Phenylpropyl
3-Allyloxyphenyl
yl)-propyl
2 0 3-(Pyridin-3-
3-Phenylpropyl
3-Isopropoxyphenyl
yl)-propyl
2 0 3-(Thiophen-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
2-yl)-propyl
2 0 3-(4-Carboxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl)
propyl
2 0 3-Phenylbutyl
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
2 0 2-Hydroxy- 3-Phenylpropyl
3,4,6-Trimethoxyphenyl
methyl-
phenyl
2 0 2-Allyloxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl
2 0 3-(3-Hydroxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
methyl-
phenyl)
propyl
2 0 3-(3-Carboxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl)
propyl
2 0 3-Hydroxy- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
methyl-
phenyl
2 0 2-Hydroxy- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl
2 0 Pyridin-3-yl
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
2 0 3-(Thiophen-
4-Phenylbutyl
3,4,5-Trimethoxyphenyl
2-yl)-propyl
2 0 5-Phenyl- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
pentyl
______________________________________
Claim 9
Dependent Claim
275 words
A compound of formula (II): ##STR21## wherein n, m, B, D and U are defined as follows: ______________________________________
n m B D U
______________________________________
1 0 3-(Pyridin-2-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
yl)propyl
2 0 3-Phenyl- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
propyl
2 0 2-Phenoxy- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl
2 0 Phenyl 2-Phenoxy-
3,4,5-Trimethoxyphenyl
phenyl
2 0 Phenyl 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
2 0 2-(Pyridin-3-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
yl)ethyl
2 0 E-3-[trans-(4-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
Hydroxy-
cyclohexyl)]-
2-methyl-eth-
2-enyl
2 0 3-(Pyridin-3-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
yl)propyl
2 0 Benzyl 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
2 0 Benzyl 3-(Indol-3-yl)
3,4,5-Trimethoxyphenyl
propyl
2 0 2-Phenylethyl
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
2 0 2-(4-Methoxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl)ethyl
2 0 2-(4-Methoxy-
3-Phenylpropyl
Phenyl
phenyl)ethyl
2 0 3-(N- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
Benzimida-
zolyl)propyl
2 1 Benzyl 2-Phenylethyl
3,4,5-Trimethoxyphenyl
2 0 3-(4-Methoxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl)
propyl
2 0 3-(Pyridin-3-
3-Phenylpropyl
Phenyl
yl)-propyl
2 0 3-(Pyridin-2-
3-Phenylpropyl
Phenyl
yl)-propyl
2 0 3-(Pyridin-2-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
yl)-propyl
2 0 3-(Pyridin-
3-Phenylpropyl
tert-Butyl
2yl)-propyl
2 0 3-(Pyridin-3-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
yl)-propyl
N-oxide
2 0 3-IN-(7- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
Azaindolyl)-
propyl
2 0 3-(Pyridin-
3-(4-Methoxy-
3,4,5-Trimethoxyphenyl
3-yl)-propyl
phenyl)propyl
2 0 3-(N-Purinyl)
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
propyl
2 0 3-(4-Hydroxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
methyl-
phenyl)
propyl
2 0 3-(Pyridin-3-
3-Phenylpropyl
3-Benzyloxyphenyl
yl)-propyl
2 0 3-(Pyridin-3-
3-Phenylpropyl
3-Allyloxyphenyl
yl)-propyl
2 0 3-(Pyridin-3-
3-Phenylpropyl
3-Isopropoxyphenyl
yl)-propyl
2 0 3-(Thiophen-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
2-yl)-propyl
2 0 3-(4-Carboxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl)
propyl
2 0 3-Phenylbutyl
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
2 0 2-Hydroxy- 3-Phenylpropyl
3,4,6-Trimethoxyphenyl
methyl-
phenyl
2 0 2-Allyloxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl
2 0 3-(3-Hydroxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
methyl-
phenyl)
propyl
2 0 3-(3-Carboxy-
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl)
propyl
2 0 3-Hydroxy- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
methyl-
phenyl
2 0 2-Hydroxy- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
phenyl
2 0 Pyridin-3-yl
3-Phenylpropyl
3,4,5-Trimethoxyphenyl
2 0 3-(Thiophen-
4-Phenylbutyl
3,4,5-Trimethoxyphenyl
2-yl)-propyl
2 0 5-Phenyl- 3-Phenylpropyl
3,4,5-Trimethoxyphenyl
pentyl
______________________________________
Claim 10
Dependent Claim
594 words
A compound of formula (II): ##STR22## wherein n, m, B, D and U are defined as follows: ______________________________________
n m B D U
______________________________________
2 0 3-Allyloxypropyl
3-Phenylpropyl
3,4,5-Tri-
methoxyphenol
2 0 3-[4-(N,N-Di 3-Phenylpropyl
3,4,5-Tri-
methylamine- methoxyphenol
carbonyl)-phenyl]
propyl
2 0 3-14-(Morpholino-
3-Phenylpropyl
3,4,5-Tri-
4-carbonyl) methoxyphenol
phenyl)-propyl
2 0 4-Allyoxybutyl
3-Phenylpropyl
3,4,5-Tri-
methoxyphenol
2 0 3-Allyloxy- 3-Phenylpropyl
3,4,5-Tri-
prop-1-ynyl methoxyphenol
2 0 3[4-(Piperi- 3-Phenylpropyl
3,4,5-Tri-
dine-1-carbonyl) methoxyphenol
phenyl)-propyl
2 0 5-Allyloxynonyl
3-Phenylpropyl
3,4,5-Tri-
methoxyphenol
2 0 Methyl 3,5-Bis(benzyl-
3,4,5-Tri-
oxy)phenyl methoxyphenol
2 0 2-Allyloxyethyl
3-Phenylpropyl
3,4,5-Tri-
methoxyphenol
2 0 3-Allyloxy-(E)-
3-Phenylpropyl
3,4,5-Tri-
prop-l-onyl methoxyphenol
2 0 3-13-(Morpho-
3-Phenylpropyl
3,4,5-Tri-
lino-4-carbonyl) methoxyphenol
phenyl]propyl
2 0 Dec-9-enyl 3-Phenylpropyl
3,4,5-Tri-
methoxyphenol
2 0 3-[4-(N-Benzyl
3-Phenylpropyl
3,4,5-Tri-
aminecarbonyl)- methoxyphenol
phenyl]propyl
2 0 3-[4-(Thiomorpho-
3-Phenylpropyl
3,4,5-Tri-
lino-4-carbonyl)- methoxyphenol
phenyl]propyl
2 0 3-(Morpholino-4-
3-Phenylpropyl
3,4,5-Tri-
carbonyl)phenyl- methoxyphenol
2 0 3-[4-(1-Methyl-
3-Phenylpropyl
3,4,5-Tri-
piperazine-4- methoxyphenol
carbonyl)-phenyl]
propyl
2 0 3-[4-(1-Benzyl-
3-Phenylpropyl
3,4,5-Tri-
piperazine-4- methoxyphenol
carbonyl)-phenyl]
propyl
2 0 3-[3-(N-Benzyl-
3-Phenylpropyl
3,4,5-Tri-
aminecarbonyl)- methoxyphenol
phenylpropyl
2 0 3-[4-(N-Pyridin-
3-Phenylpropyl
3,4,5-Tri-
2-ylaminecarbon- methoxyphenol
yl)-phenyl]propyl
2 0 Pryidin-3-yl 3-(Pyridin-3-yl)-
3,4,5-Tri-
propyl methoxyphenol
2 0 Prop-2-enyl 3,4-Bis-(Pyridin-4-
3,4,5-Tri-
ylmethoxy)phenyl
methoxyphenol
2 0 Pyridin-3-yl 3-(Pyridin-4-yl-
3,4,5-Tri-
methoxy)phenyl
methoxyphenol
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3,4,5-Tri-
methoxy)phenyl
methoxyphenol
2 0 3-Phenylpropyl
3,4-Bis-(Pyridin-4-
3,4,5-Tri-
ylmethoxy)phenyl
methoxyphenol
2 0 Methyl 3,4-Bis-(Pyridin-4-
3,4,5-Tri-
ylmethoxy)phenyl
methoxyphenol
2 0 3-Phenylpropyl
2,3,4-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3-Phenylpropyl
3-(Morpholino-4-
3,4,5-Tri-
carbonyl)-4-
methoxyphenol
(Pyridin-4-yl-
methoxy)phenyl
2 0 Methyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3-Phenylpropyl
3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 Methyl 3,5-Bis-(Pyridin-4-
3,4,5-Tri-
ylmethoxy)phenyl
methoxyphenol
2 0 3,5-Bis-(Pyridin-
Methyl 3,4,5-Tri-
4-ylmethoxy) methoxyphenol
phenyl
2 0 Methyl 3,5-Bis-(Pyridin-4-
3,4,5-Tri-
y[methoxy)-4-
methoxyphenol
Methyl-phenyl
2 0 Ethyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3,4,5-Tris- Ethyl 3,4,5-Tri-
(Pyridin-4-yl- methoxyphenol
methoxy)phenyl
2 0 Prop-2-enyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 Methyl 3,4,6-Tris-(Pyridin-
3,4-Di-
4-ylmethoxy)phenyl
methoxyphenyl
2 0 Ethenyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3,4,5-Tris- Ethenyl 3,4,5-Tri-
(Pyridin-4- methoxyphenol
ylmethoxy)phenyl
2 0 Propyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3,4,5-Tris- Propyl 3,4,5-Tri-
(Pyridin-4- methoxyphenol
ylmethoxy)phenyl
2 0 Methyl 3,4,5-Tris- 3,4,5-Tri-
(Thiophen-3-yl-
methoxyphenol
methoxy)phenyl
2 0 3,4,5-Tris- Methyl 3,4,5-Tri-
(Thio-phen-3- methoxyphenol
ylmethoxy)-
phenyl
2 0 Methyl 2-isopropoxy-3,4-
3,4,5-Tri-
Bis-(Pyridin-4-
methoxyphenol
ylmethoxy)-phenyl
2 0 2-Isopropoxy-
Methyl 3,4,5-Tri-
3,4-Bis-(Pyridin- methoxyphenol
4-yl-methoxy)
phenyl
1 0 Methyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
1 0 3,4,5-Tris- Methyl 3,4,5-Tri-
(Pyridin-4- methoxyphenol
ylmethoxy)phenyl
2 0 Methyl 3,4,5-Tris- 3,4,5-Tri-
(Pyrimidin-4-
methoxyphenol
ylmethoxy)phenyl
2 0 Benzyloxymethyl
Benzyloxyphenyl
3,4,5-Tri-
methoxyphenol
2 0 Methyl 3,4,5-Tris-(Benzyl-
3,4,5-Tri-
oxy)phenyl methoxyphenol
2 0 3-Phenylpropyl
3-(Pyridin-3-yl-
3,4,5-Tri-
carbonyl)phenyl
methoxyphenol
2 0 3-(Pyridin-3-yl-
3-Phenylpropyl
3,4,5-Tri-
carbonyl)phenyl methoxyphenol
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3,4-Di-
methoxy)phenyl
methoxyphenol
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
4-Benzyloxy-
carbonyl)phenyl
3,5-Dimethoxy-
phenyl
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
4-Allylyoxy-3,5-
carbonyl)phenyl
Dimethoxy-
phenyl
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3-Benzyloxy-4-
carbonyl)phenyl
methoxyphenyl
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3-Allyloxy-4-
carbonyl)phenyl
methoxyphenyl
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3-[3-Phenyl-(E)-
carbonyl)phenyl
prop-2-enyl]-4-
methoxyphenyl
2 0 3-Phenylpropyl
4-(Pyridin-4-yl-
4-Benzyloxy-
carbonyl)phenyl
3,5-Dimethoxy-
phenyl
2 0 3-Phenylpropyl
4-(Pyridin-4-yl-
3-Benzyloxy-4-
carbonyl)phenyl
methoxyphenyl
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3,4,5-Tri-
carbonyl)phenyl
methoxyphenol
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3,4-Di-
carbonyl)phenyl
methoxyphenyl
2 0 3-Phenylpropyl
Phenyl 3-Benzyloxy-4-
methoxyphenyl
2 0 3-Phenylpropyl
Phenyl 4-Benzyloxy-
3,5-Dimethoxy-
phenyl
1 0 3-(Pyridin-3-
3-Phenylpropyl
tert-Butyl
yl)-propyl
2 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
3,4,5-Tri-
yl)-propyl propyl methoxyphenol
1 0 Benzyloxymethyl
Benzyloxyphenyl
3,4,5-Tri-
methoxyphenol
1 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
3,4,5-Tri-
yl-propyl propyl methoxyphenol
2 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
Isopropyl
yl)-propyl propyl
2 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
Thiophen-2-yl
yl)-
2 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
3,4-Methylene-
yl)-propyl propyl dioxyphenyl
2 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
3,4-Methylene-
yl)-prop-2-ynyl
prop-2-ynyl dioxyphenyl
2 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
3,4,5-Tri-
yl)-prop-2-ynyl
prop-2-ynyl methoxyphenol
2 0 3-(Pyridin-2-
3-(Pyridin-2-yl)-
3,4,5-Tri-
yl-propyl propyl methoxyphenol
2 0 Isopropyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3,4,5-Tris- Isopropyl 3,4,5-Tri-
(Pyridin-4- methoxyphenol
ylmethoxy)phenyl
2 0 Prop-2-enyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3,4,5-Tris- Prop-2-enyl 3,4,5-Tri-
(Pyridin-4- methoxyphenol
ylmethoxy)phenyl
______________________________________
Claim 11
Dependent Claim
594 words
A compound of formula (II): ##STR22## wherein n, m, B, D and U are defined as follows: ______________________________________
n m B D U
______________________________________
2 0 3-Allyloxypropyl
3-Phenylpropyl
3,4,5-Tri-
methoxyphenol
2 0 3-[4-(N,N-Di 3-Phenylpropyl
3,4,5-Tri-
methylamine- methoxyphenol
carbonyl)-phenyl]
propyl
2 0 3-14-(Morpholino-
3-Phenylpropyl
3,4,5-Tri-
4-carbonyl) methoxyphenol
phenyl)-propyl
2 0 4-Allyoxybutyl
3-Phenylpropyl
3,4,5-Tri-
methoxyphenol
2 0 3-Allyloxy- 3-Phenylpropyl
3,4,5-Tri-
prop-1-ynyl methoxyphenol
2 0 3[4-(Piperi- 3-Phenylpropyl
3,4,5-Tri-
dine-1-carbonyl) methoxyphenol
phenyl)-propyl
2 0 5-Allyloxynonyl
3-Phenylpropyl
3,4,5-Tri-
methoxyphenol
2 0 Methyl 3,5-Bis(benzyl-
3,4,5-Tri-
oxy)phenyl methoxyphenol
2 0 2-Allyloxyethyl
3-Phenylpropyl
3,4,5-Tri-
methoxyphenol
2 0 3-Allyloxy-(E)-
3-Phenylpropyl
3,4,5-Tri-
prop-l-onyl methoxyphenol
2 0 3-13-(Morpho-
3-Phenylpropyl
3,4,5-Tri-
lino-4-carbonyl) methoxyphenol
phenyl]propyl
2 0 Dec-9-enyl 3-Phenylpropyl
3,4,5-Tri-
methoxyphenol
2 0 3-[4-(N-Benzyl
3-Phenylpropyl
3,4,5-Tri-
aminecarbonyl)- methoxyphenol
phenyl]propyl
2 0 3-[4-(Thiomorpho-
3-Phenylpropyl
3,4,5-Tri-
lino-4-carbonyl)- methoxyphenol
phenyl]propyl
2 0 3-(Morpholino-4-
3-Phenylpropyl
3,4,5-Tri-
carbonyl)phenyl- methoxyphenol
2 0 3-[4-(1-Methyl-
3-Phenylpropyl
3,4,5-Tri-
piperazine-4- methoxyphenol
carbonyl)-phenyl]
propyl
2 0 3-[4-(1-Benzyl-
3-Phenylpropyl
3,4,5-Tri-
piperazine-4- methoxyphenol
carbonyl)-phenyl]
propyl
2 0 3-[3-(N-Benzyl-
3-Phenylpropyl
3,4,5-Tri-
aminecarbonyl)- methoxyphenol
phenylpropyl
2 0 3-[4-(N-Pyridin-
3-Phenylpropyl
3,4,5-Tri-
2-ylaminecarbon- methoxyphenol
yl)-phenyl]propyl
2 0 Pryidin-3-yl 3-(Pyridin-3-yl)-
3,4,5-Tri-
propyl methoxyphenol
2 0 Prop-2-enyl 3,4-Bis-(Pyridin-4-
3,4,5-Tri-
ylmethoxy)phenyl
methoxyphenol
2 0 Pyridin-3-yl 3-(Pyridin-4-yl-
3,4,5-Tri-
methoxy)phenyl
methoxyphenol
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3,4,5-Tri-
methoxy)phenyl
methoxyphenol
2 0 3-Phenylpropyl
3,4-Bis-(Pyridin-4-
3,4,5-Tri-
ylmethoxy)phenyl
methoxyphenol
2 0 Methyl 3,4-Bis-(Pyridin-4-
3,4,5-Tri-
ylmethoxy)phenyl
methoxyphenol
2 0 3-Phenylpropyl
2,3,4-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3-Phenylpropyl
3-(Morpholino-4-
3,4,5-Tri-
carbonyl)-4-
methoxyphenol
(Pyridin-4-yl-
methoxy)phenyl
2 0 Methyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3-Phenylpropyl
3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 Methyl 3,5-Bis-(Pyridin-4-
3,4,5-Tri-
ylmethoxy)phenyl
methoxyphenol
2 0 3,5-Bis-(Pyridin-
Methyl 3,4,5-Tri-
4-ylmethoxy) methoxyphenol
phenyl
2 0 Methyl 3,5-Bis-(Pyridin-4-
3,4,5-Tri-
y[methoxy)-4-
methoxyphenol
Methyl-phenyl
2 0 Ethyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3,4,5-Tris- Ethyl 3,4,5-Tri-
(Pyridin-4-yl- methoxyphenol
methoxy)phenyl
2 0 Prop-2-enyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 Methyl 3,4,6-Tris-(Pyridin-
3,4-Di-
4-ylmethoxy)phenyl
methoxyphenyl
2 0 Ethenyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3,4,5-Tris- Ethenyl 3,4,5-Tri-
(Pyridin-4- methoxyphenol
ylmethoxy)phenyl
2 0 Propyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3,4,5-Tris- Propyl 3,4,5-Tri-
(Pyridin-4- methoxyphenol
ylmethoxy)phenyl
2 0 Methyl 3,4,5-Tris- 3,4,5-Tri-
(Thiophen-3-yl-
methoxyphenol
methoxy)phenyl
2 0 3,4,5-Tris- Methyl 3,4,5-Tri-
(Thio-phen-3- methoxyphenol
ylmethoxy)-
phenyl
2 0 Methyl 2-isopropoxy-3,4-
3,4,5-Tri-
Bis-(Pyridin-4-
methoxyphenol
ylmethoxy)-phenyl
2 0 2-Isopropoxy-
Methyl 3,4,5-Tri-
3,4-Bis-(Pyridin- methoxyphenol
4-yl-methoxy)
phenyl
1 0 Methyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
1 0 3,4,5-Tris- Methyl 3,4,5-Tri-
(Pyridin-4- methoxyphenol
ylmethoxy)phenyl
2 0 Methyl 3,4,5-Tris- 3,4,5-Tri-
(Pyrimidin-4-
methoxyphenol
ylmethoxy)phenyl
2 0 Benzyloxymethyl
Benzyloxyphenyl
3,4,5-Tri-
methoxyphenol
2 0 Methyl 3,4,5-Tris-(Benzyl-
3,4,5-Tri-
oxy)phenyl methoxyphenol
2 0 3-Phenylpropyl
3-(Pyridin-3-yl-
3,4,5-Tri-
carbonyl)phenyl
methoxyphenol
2 0 3-(Pyridin-3-yl-
3-Phenylpropyl
3,4,5-Tri-
carbonyl)phenyl methoxyphenol
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3,4-Di-
methoxy)phenyl
methoxyphenol
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
4-Benzyloxy-
carbonyl)phenyl
3,5-Dimethoxy-
phenyl
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
4-Allylyoxy-3,5-
carbonyl)phenyl
Dimethoxy-
phenyl
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3-Benzyloxy-4-
carbonyl)phenyl
methoxyphenyl
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3-Allyloxy-4-
carbonyl)phenyl
methoxyphenyl
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3-[3-Phenyl-(E)-
carbonyl)phenyl
prop-2-enyl]-4-
methoxyphenyl
2 0 3-Phenylpropyl
4-(Pyridin-4-yl-
4-Benzyloxy-
carbonyl)phenyl
3,5-Dimethoxy-
phenyl
2 0 3-Phenylpropyl
4-(Pyridin-4-yl-
3-Benzyloxy-4-
carbonyl)phenyl
methoxyphenyl
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3,4,5-Tri-
carbonyl)phenyl
methoxyphenol
2 0 3-Phenylpropyl
3-(Pyridin-4-yl-
3,4-Di-
carbonyl)phenyl
methoxyphenyl
2 0 3-Phenylpropyl
Phenyl 3-Benzyloxy-4-
methoxyphenyl
2 0 3-Phenylpropyl
Phenyl 4-Benzyloxy-
3,5-Dimethoxy-
phenyl
1 0 3-(Pyridin-3-
3-Phenylpropyl
tert-Butyl
yl)-propyl
2 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
3,4,5-Tri-
yl)-propyl propyl methoxyphenol
1 0 Benzyloxymethyl
Benzyloxyphenyl
3,4,5-Tri-
methoxyphenol
1 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
3,4,5-Tri-
yl-propyl propyl methoxyphenol
2 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
Isopropyl
yl)-propyl propyl
2 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
Thiophen-2-yl
yl)-
2 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
3,4-Methylene-
yl)-propyl propyl dioxyphenyl
2 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
3,4-Methylene-
yl)-prop-2-ynyl
prop-2-ynyl dioxyphenyl
2 0 3-(Pyridin-3-
3-(Pyridin-3-yl)-
3,4,5-Tri-
yl)-prop-2-ynyl
prop-2-ynyl methoxyphenol
2 0 3-(Pyridin-2-
3-(Pyridin-2-yl)-
3,4,5-Tri-
yl-propyl propyl methoxyphenol
2 0 Isopropyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3,4,5-Tris- Isopropyl 3,4,5-Tri-
(Pyridin-4- methoxyphenol
ylmethoxy)phenyl
2 0 Prop-2-enyl 3,4,5-Tris-(Pyridin-
3,4,5-Tri-
4-ylmethoxy)phenyl
methoxyphenol
2 0 3,4,5-Tris- Prop-2-enyl 3,4,5-Tri-
(Pyridin-4- methoxyphenol
ylmethoxy)phenyl
______________________________________
Claim 12
Dependent Claim
62 words
The compound according to claim 1, wherein, in formula (I), at least one of B or D is independently represented by the formula --(CH 2 ) r --(X)--(CH 2 ) s --Ar 2 , wherein: r is 0-4; s is 0-1; and each X is independently selected from the group consisting of CH 2 , O, S, SO, and SO 2 .
Claim 13
Dependent Claim
21 words
A compound selected from the group consisting of: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, and mixtures thereof.
Claim 14
Dependent Claim
21 words
A compound selected from the group consisting of: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, and mixtures thereof.
Claim 15
Dependent Claim
53 words
A pharmaceutical composition comprising: a compound selected from: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, mixtures thereof, other compounds of formula (II) and other compounds of formula (I), said compound being present in an amount effective to treat or prevent multi-drug resistance; and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Claim 16
Dependent Claim
53 words
A pharmaceutical composition comprising: a compound selected from: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, mixtures thereof, other compounds of formula (II) and other compounds of formula (I), said compound being present in an amount effective to treat or prevent multi-drug resistance; and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Claim 17
Dependent Claim
12 words
The pharmaceutical composition according to claim 10, further comprising a chemotherapeutic agent.
Claim 18
Dependent Claim
21 words
The pharmaceutical composition according to claim 10 or 11, further comprising a chemosensitizer other than a compound according to formula (I).
Claim 19
Dependent Claim
55 words
A pharmaceutical composition comprising: a compound selected from: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, mixtures thereof, other compounds of formula (II) and other compounds of formula (I), said compound being present in an amount effective to reduce, suppress or prevent an immune response; and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Claim 20
Dependent Claim
55 words
A pharmaceutical composition comprising: a compound selected from: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, mixtures thereof, other compounds of formula (II) and other compounds of formula (I), said compound being present in an amount effective to reduce, suppress or prevent an immune response; and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Claim 21
Dependent Claim
25 words
The pharmaceutical composition according to claim 13, further comprising an immunosuppressant selected from the group consisting of cyclosporin A, rapamycin, FK-506, 15-deoxyspergualin, OKT3 and azathioprine.
Claim 22
Dependent Claim
23 words
The pharmaceutical composition according to claim 13 or 14, further comprising an immunosuppressant selected from the group consisting of micophenolic acid and brequinar.
Claim 23
Dependent Claim
13 words
The pharmaceutical composition according to claim 13 or 14, further comprising a steroid.
Claim 24
Independent Claim
649 words
A method for treating or preventing multi-drug resistance in a patient comprising the step of administering to said patient a pharmaceutical composition comprising: a compound in an amount effective to treat or prevent said multi-drug resistance; and a pharmaceutically acceptable carrier, adjuvant or vehicle; said compound being a compound of formula (I): ##STR23## wherein: A is CH 2 , oxygen, NH or N--(C1-C4 alkyl); B and D are independently: (i) hydrogen, Ar 1 , (C1-C10)-straight or branched alkyl, (C2-C10)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl substituted (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl substituted (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl, or Ar 1 substituted (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl wherein, in each case, any one of the CH 2 groups of said alkyl, alkenyl or alkynyl chains may be optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 , N, and NR, wherein R is selected from the group consisting of hydrogen, (C1-C4)-straight or branched alkyl, (C2-C4)-straight or branched alkenyl or alkynyl, and (C1-C4) bridging alkyl wherein a bridge is formed between the nitrogen and a carbon atom of said heteroatom-containing chain to form a ring, and wherein said ring is optionally fused to an Ar 1 group; or ##STR24## (ii) wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl; wherein T is Ar 1 or substituted 5-7 membered cycloalkyl with substituents at positions 3 and 4 which are independently selected from the group consisting of oxo, hydrogen, hydroxyl, O--(C1-C4)-alkyl, and O--(C2-C4)-alkenyl; wherein Ar 1 is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazolyl, 1,3,4-thiadiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl, 1H-indazolyl, benzimidazolyl, benzthiazolyl, purinyl, 4H-quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl; wherein any occurrence of Ar 1 may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--[(C1-C4)-straight or branched alkyl], O--[(C2-C4)-straight or branched alkenyl], O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl, N-[(C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N,N-di-[(C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)]carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen, then L is not hydrogen; wherein U is hydrogen, O--[(C1-C4)-straight or branched alkyl] or O--[(C2-C4)straight or branched alkenyl], (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl or (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, [(C1-C4)-alkyl or (C2-C4)-alkenyl]-Y or Y; wherein Y is selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, anthracenyl, 2-pyrrolinyl, 3-pyrrolinyl, pyrolidinyl, 1,3-dioxolyl, 2-imidazolinyl, imidazolidinyl, 2H-pyranyl, 4H-pyranyl, piperidyl, 1,4-dioxanyl, morpholinyl, 1,4-dithianyl, thiomorpholinyl, piperazinyl, quinuclidinyl, and heterocyclic aromatic groups as defined above; wherein Y may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--[(C1-C4)-straight or branched alkyl], O--[(C2-C4)-straight or branched alkenyl], O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, and carboxyl; J and K are taken together with the N and C atoms to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; and m is 0-3.
Claim 25
Independent Claim
649 words
A method for treating or preventing multi-drug resistance in a patient comprising the step of administering to said patient a pharmaceutical composition comprising: a compound in an amount effective to treat or prevent said multi-drug resistance; and a pharmaceutically acceptable carrier, adjuvant or vehicle; said compound being a compound of formula (I): ##STR23## wherein: A is CH 2 , oxygen, NH or N--(C1-C4 alkyl); B and D are independently: (i) hydrogen, Ar 1 , (C1-C10)-straight or branched alkyl, (C2-C10)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl substituted (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl substituted (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl, or Ar 1 substituted (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl wherein, in each case, any one of the CH 2 groups of said alkyl, alkenyl or alkynyl chains may be optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 , N, and NR, wherein R is selected from the group consisting of hydrogen, (C1-C4)-straight or branched alkyl, (C2-C4)-straight or branched alkenyl or alkynyl, and (C1-C4) bridging alkyl wherein a bridge is formed between the nitrogen and a carbon atom of said heteroatom-containing chain to form a ring, and wherein said ring is optionally fused to an Ar 1 group; or ##STR24## (ii) wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl; wherein T is Ar 1 or substituted 5-7 membered cycloalkyl with substituents at positions 3 and 4 which are independently selected from the group consisting of oxo, hydrogen, hydroxyl, O--(C1-C4)-alkyl, and O--(C2-C4)-alkenyl; wherein Ar 1 is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazolyl, 1,3,4-thiadiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl, 1H-indazolyl, benzimidazolyl, benzthiazolyl, purinyl, 4H-quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl; wherein any occurrence of Ar 1 may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--[(C1-C4)-straight or branched alkyl], O--[(C2-C4)-straight or branched alkenyl], O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl, N-[(C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N,N-di-[(C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)]carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen, then L is not hydrogen; wherein U is hydrogen, O--[(C1-C4)-straight or branched alkyl] or O--[(C2-C4)straight or branched alkenyl], (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl or (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, [(C1-C4)-alkyl or (C2-C4)-alkenyl]-Y or Y; wherein Y is selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, anthracenyl, 2-pyrrolinyl, 3-pyrrolinyl, pyrolidinyl, 1,3-dioxolyl, 2-imidazolinyl, imidazolidinyl, 2H-pyranyl, 4H-pyranyl, piperidyl, 1,4-dioxanyl, morpholinyl, 1,4-dithianyl, thiomorpholinyl, piperazinyl, quinuclidinyl, and heterocyclic aromatic groups as defined above; wherein Y may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--[(C1-C4)-straight or branched alkyl], O--[(C2-C4)-straight or branched alkenyl], O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, and carboxyl; J and K are taken together with the N and C atoms to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; and m is 0-3.
Claim 26
Independent Claim
580 words
A method for treating or preventing multi-drug resistance in a patient comprising the step of administering to said patient a pharmaceutical composition comprising: a compound in an amount effective to treat or prevent said multi-drug resistance; and a pharmaceutically acceptable carrier, adjuvant or vehicle; said compound being a compound of formula (I): ##STR25## wherein: A is CH 2 , oxygen, NH or N--(C1-C4 alkyl); B and D are independently (i) Ar 1 , (C1-C10)-straight or branched alkyl, (C2-C10)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, or Ar 1 -substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl wherein, in each case, any one of the CH 2 groups of said alkyl, alkenyl or alkynyl chains may be optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 ; or ##STR26## (ii) wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl; wherein T is Ar 1 or substituted 5-7 membered cycloalkyl with substitutents at positions 3 and 4 which are independently selected from the group consisting of oxo, hydrogen, hydroxyl, O--(C1-C4)-alkyl or O--(C2-C4)-alkenyl; wherein Ar 1 is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, 2-pyrazolinyl, pyrazolidinyl, isoxazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazolyl, 1,3,4-thiadiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl, 1H-indazolyl, benzimidazolyl, benzthiazolyl, purinyl, 4H-quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl; wherein any occurrence of Ar 1 may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl, N-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N,N-di-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen, then L is not hydrogen; wherein U is hydrogen, O--((C1-C4)-straight or branched alkyl) or O--((C2-C4)straight or branched alkenyl), (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl or (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, [(C1-C4)-alkyl or (C2-C4)-alkenyl]-Y or Y; wherein Y is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, anthracenyl; or a heterocyclic aromatic group as defined above; wherein Y may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, and carboxyl; J and K are taken together with the N and C atoms to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; and m is 0-3.
Claim 27
Independent Claim
580 words
A method for treating or preventing multi-drug resistance in a patient comprising the step of administering to said patient a pharmaceutical composition comprising: a compound in an amount effective to treat or prevent said multi-drug resistance; and a pharmaceutically acceptable carrier, adjuvant or vehicle; said compound being a compound of formula (I): ##STR25## wherein: A is CH 2 , oxygen, NH or N--(C1-C4 alkyl); B and D are independently (i) Ar 1 , (C1-C10)-straight or branched alkyl, (C2-C10)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, or Ar 1 -substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl wherein, in each case, any one of the CH 2 groups of said alkyl, alkenyl or alkynyl chains may be optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 ; or ##STR26## (ii) wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl; wherein T is Ar 1 or substituted 5-7 membered cycloalkyl with substitutents at positions 3 and 4 which are independently selected from the group consisting of oxo, hydrogen, hydroxyl, O--(C1-C4)-alkyl or O--(C2-C4)-alkenyl; wherein Ar 1 is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, 2-pyrazolinyl, pyrazolidinyl, isoxazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazolyl, 1,3,4-thiadiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl, 1H-indazolyl, benzimidazolyl, benzthiazolyl, purinyl, 4H-quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl; wherein any occurrence of Ar 1 may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl, N-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N,N-di-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen, then L is not hydrogen; wherein U is hydrogen, O--((C1-C4)-straight or branched alkyl) or O--((C2-C4)straight or branched alkenyl), (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl or (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, [(C1-C4)-alkyl or (C2-C4)-alkenyl]-Y or Y; wherein Y is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, anthracenyl; or a heterocyclic aromatic group as defined above; wherein Y may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, and carboxyl; J and K are taken together with the N and C atoms to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; and m is 0-3.
Claim 28
Dependent Claim
48 words
The method according to claim 17 or 18, wherein at least one of B or D is independently selected from the group consisting of (C2-C10)-straight or branched alkynyl; (C5-C7)-cycloalkyl substituted (C2-C6)-straight or branched alkynyl; (C5-C7)-cycloalkenyl substituted (C2-C6)-straight or branched alkynyl; and Ar 1 -substituted (C2-C6)-straight or branched alkynyl.
Claim 29
Dependent Claim
117 words
The method according to claim 17 or 18, wherein, at least one of B or D is independently selected from the group consisting of Ar', Ar'-substituted (C1-C6)-straight or branched alkyl, and Ar'-substituted (C2-C6)-straight or branched alkenyl or alkynyl; wherein Ar' is an Ar group substituted with one to three substituents which are independently selected from the group consisting of N-(straight or branched (C1-C5)-alkyl or (C2-C5)-alkenyl) carboxamides, N,N-di-(straight or branched (C1-C5)-alkyl or (C2-C5)-alkenyl)carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2.
Claim 30
Dependent Claim
99 words
The method according to claim 17, wherein at least one of B or D is independently represented by the formula --(CH 2 ) r --(X)--(CH 2 ) s --Ar 1 , wherein: r is 0-4; s is 0-1; and each X is independently selected from the group consisting of CH 2 , O, S, SO, SO 2 , N, and NR, wherein R is selected from the group consisting of hydrogen, (C1-C4)-straight or branched alkyl, (C2-C4)-straight or branched alkenyl or alkynyl, and (C1-C4) bridging alkyl, wherein a bridge is formed between the nitrogen atom and the Ar 1 group.
Claim 31
Dependent Claim
34 words
The method according to claim 17 or 18, wherein said compound of formula (I) is selected from the group consisting of: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, and mixtures thereof.
Claim 32
Dependent Claim
60 words
A method for reducing, suppressing or preventing an immune response in a mammal comprising the step of administering to said mammal a pharmaceutical composition comprising; a compound in an amount effective to reduce, suppress or prevent said immune response; and a pharmaceutically acceptable carrier, adjuvant or vehicle; said compound being a compound of formula (I) as defined in claim 1.
Claim 33
Dependent Claim
31 words
The method according to claim 23, further comprising the step of administering to said mammal an immunosuppressant selected from the group consisting of cyclosporin A, rapamycin, FK-506, 15-deoxyspergualin, OKT3 and azathioprine.
Claim 34
Dependent Claim
17 words
The method according to claim 23, further comprising the step of administering a steroid to said mammal.
Claim 35
Independent Claim
18 words
The method according to any one of claims 19, 18 or 23, wherein the compound is administered orally.
Claim 36
Dependent Claim
23 words
The method according to claim 17 or 18, wherein the compound is not substantially immunosuppressive at the dosage level required to cause chemosensitization.